These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9827515)

  • 1. von Hippel-Lindau gene mutations in human and rodent renal tumors--association with clear cell phenotype.
    Gnarra JR
    J Natl Cancer Inst; 1998 Nov; 90(22):1685-7. PubMed ID: 9827515
    [No Abstract]   [Full Text] [Related]  

  • 2. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors.
    Shiao YH; Rice JM; Anderson LM; Diwan BA; Hard GC
    J Natl Cancer Inst; 1998 Nov; 90(22):1720-3. PubMed ID: 9827526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell type.
    Meyer AJ; Hernandez A; Florl AR; Enczmann J; Gerharz CD; Schulz WA; Wernet P; Ackermann R
    Int J Cancer; 2000 Sep; 87(5):650-3. PubMed ID: 10925357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited renal cell carcinoma.
    Maher ER
    Br J Urol; 1996 Oct; 78(4):542-5. PubMed ID: 8944511
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
    Linehan WM; Lerman MI; Zbar B
    JAMA; 1995 Feb; 273(7):564-70. PubMed ID: 7837390
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing in on another renal cancer suppressor locus near chromosome 3p14.
    Kaye FJ
    J Natl Cancer Inst; 1999 Sep; 91(18):1528-9. PubMed ID: 10491421
    [No Abstract]   [Full Text] [Related]  

  • 12. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
    Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
    J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
    Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
    Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the genes for kidney cancer.
    Linehan WM
    Cancer Biol Ther; 2006 Jun; 5(6):696-9. PubMed ID: 16775424
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers.
    Bailly M; Bain C; Favrot MC; Ozturk M
    Int J Cancer; 1995 Nov; 63(5):660-4. PubMed ID: 7591282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial non-VHL non-papillary clear-cell renal cancer.
    Teh BT; Giraud S; Sari NF; Hii SI; Bergerat JP; Larsson C; Limacher JM; Nicol D
    Lancet; 1997 Mar; 349(9055):848-9. PubMed ID: 9121264
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
    Sufan RI; Jewett MA; Ohh M
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F1-6. PubMed ID: 15180922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic basis of renal cell cancer.
    Linehan WM; Gnarra JR; Lerman MI; Latif F; Zbar B
    Important Adv Oncol; 1993; ():47-70. PubMed ID: 8505056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.